Form 4 for COCH Envoy Medical, Inc.
Accepted 2023-11-24 00:00:00 ET · period of report 2023-11-21 · accession 0001062993-23-021438 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2023-11-24 | 2023-11-21 | COCH | Lucas Brent T. | CEO, Dir | P - Purchase | $0.9685 | +12.4K | 120.8K | +11% | +$12.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2023-11-21 | P | A | 10,000 | $0.98 | 118,451 | D | — | — | |
| 2 | Common | Class A Common Stock | 2023-11-21 | P | A | 2,380 | $0.92 | 120,831 | D | — | — |